Filing Details
- Accession Number:
- 0001019056-23-000351
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-14 16:37:00
- Reporting Period:
- 2023-09-12
- Accepted Time:
- 2023-09-14 16:37:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831097 | Agilon Health Inc. | AGL | Services-Misc Health & Allied Services, Nec (8090) | 371915147 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1855843 | Benjamin Shaker | C/O Agilon Health, Inc. 6210 E Hwy 290, Suite 450 Austin TX 78723 | Chief Markets Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-12 | 18,750 | $3.79 | 98,293 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-09-12 | 18,750 | $18.05 | 79,543 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-09-13 | 18,750 | $3.79 | 98,293 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-09-13 | 18,750 | $18.00 | 79,543 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options (Right to buy) | Disposition | 2023-09-12 | 18,750 | $0.00 | 18,750 | $3.79 |
| Common Stock | Options (Right to buy) | Disposition | 2023-09-13 | 18,750 | $0.00 | 18,750 | $3.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 320,601 | 2029-02-09 | No | 4 | M | Direct | |
| 301,851 | 2029-02-09 | No | 4 | M | Direct |
Footnotes
- Includes restricted stock units.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.67 to $18.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- These options were granted on February 9, 2019, and became fully vested as of February 9, 2023.
Billionaire Hedge Funds
